The treatment of complex bone defects, particularly in the cranio-maxillofacial region, remains a major clinical challenge. Autologous grafts are considered the gold standard, but they are associated with limitations such as resorption, insufficient fit, and infection risks.

Novel chitosan– MoS2-nanocomposites open new perspectives for the diagnosis of neurological diseases

Dopamine is one of the most important neurotransmitters in the human brain. Its imbalance is associated with neurological disorders such as Parkinson’s disease, schizophrenia, or Huntington’s disease.

Radiation-Induced Pneumonitis as a Therapeutic Challenge

Radiotherapy remains one of the main pillars of modern cancer treatment. However, despite advances in precision targeting, damage to surrounding healthy tissue continues to pose a significant clinical problem - especially in thoracic malignancies. In such cases, the lungs represent a particularly radiosensitive organ.

Chitosan is no longer just an interesting biopolymer for the food or wound healing sectors. It is gaining attention in many other fields as well – particularly due to its radical scavenging, hematopoietic, and cytoprotective properties. One of the most promising areas of application: radioprotection, i.e., the protection of tissue from damage caused by ionizing radiation.